Stem Cell Reviews and Reports - Featured Articles: Stem Cell and COVID-19
Review of Trials Currently Testing Stem Cells for Treatment of Respiratory Diseases: Facts Known to Date and Possible Applications to COVID-19
Fernanda Majolo, Guilherme Liberato da Silva, ... Márcia Inês Goettert
Epidermal Neural Crest Stem Cells as a Perspective for COVID-19 Treatment
Mohammad Saied Salehi, Sareh Pandamooz & Benjamin Jurek
Fighting the War Against COVID-19 via Cell-Based Regenerative Medicine: Lessons Learned from 1918 Spanish Flu and Other Previous Pandemics
You Jeong Park, Jeffrey Farooq, ... Cesar V. Borlongan
Physiological Relevance of Angiotensin Converting Enzyme 2 As a Metabolic Linker and Therapeutic Implication of Mesenchymal Stem Cells in COVID-19 and Hypertension
Sarama Saha, Sasanka Chakrabarti, Praveen Kumar Singh…
Stem Cells Therapy as a Possible Therapeutic Option in Treating COVID-19 Patients
Diana Esquivel, Rangnath Mishra, Prabhat Soni…
Treatment of COVID-19 Pneumonia: the Case for Placenta-derived Cell Therapy
Ekaterine Berishvili, Laurent Kaiser, Marie Cohen…
SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45− Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome
Mariusz Z. Ratajczak, Kamila Bujko, Andrzej Ciechanowicz…
Mesenchymal Stem Cell Derived Exosomes: a Nano Platform for Therapeutics and Drug Delivery in Combating COVID-19
Pinky, Suchi Gupta, Vishnu Krishnakumar, Yashvi Sharma…
‘Primed’ Mesenchymal Stem Cells: a Potential Novel Therapeutic for COVID19 Patients
Syed Shadab Raza, Pankaj Seth, Mohsin Ali Khan
Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Range of Promises
Arefeh Basiri, Zahra Pazhouhnia, Nima Beheshtizadeh…
Is COVID-19 a New Hematologic Disease?
Benjamin Deduc & David M. Smadja
How to “Detronize” Virus in Crown – Questions to Current Stem Cell Therapies
Mariusz Z. Ratajczak
Mesenchymal Stem Cell Therapy for COVID-19: Present or Future
Ali Golchin, Ehsan Seyedjafari & Abdolreza Ardeshirylajimi
CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement
Henning Ulrich & Micheli M. Pillat